Abstract
Controlling the Smoking Epidemic: report of the WHO Expert Committee on Smoking Control. WHO Technical Report Series No. 636
Highlights
19 co-authors, tells us again of the value of immunotherapy in ALL, and James Holland does the same in AML more cautiously
The only chapter which describes objective evidence of benefit from a properly controlled trial is that by Martin McKneally whose lung cancer trial remains about the only success which is not controversial
The book ends with 3 chapters about the prospects for immunotherapy
Summary
19 co-authors, tells us again of the value of immunotherapy in ALL, and James Holland does the same in AML more cautiously. We are told about the successes (or likely successes) of immunotherapy in most forms of cancer. Others provide enthusiastic reports about most other forms of cancer.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
